Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-370 Phase II pediatric vaccine study
jRCT2080222866Phase 2
- Sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Start
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Quentiv, sponsored by The Chemo-Sero-Therapeutic Research Institute.
02
Drugs
Quentiv
Beyond the preview
Go deeper on jRCT2080222866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222866.